Alzheimers Dement

ISSN	1552-5279
ISSN-L	1552-5260
IUID	82a9e46fa07546b28664a77de7a51b59
Modified	2020-11-27T13:12:55.586Z
Created	2018-12-05T09:16:52.012Z

Year 2025

DOI Crossref

CSF and plasma proteomic insights into the pathophysiology of cerebral small vessel disease and cerebrovascular event risk prediction

Hristovska I, Binette AP, Kumar A, ..., Vogel JW, Hansson O

Alzheimers Dement 21 (S2) - [2025-12-00; online 2025-12-24]

DOI Crossref

Proteomic profiles in Lewy body pathology and the presence of AD co‐pathology

Cumplido‐Mayoral I, Hristovska I, Binette AP, ..., Mattsson‐Carlgren N, Hansson O

Alzheimers Dement 21 (S2) - [2025-12-00; online 2026-01-08]

DOI Crossref

A conditional two‐step approach for detecting Lewy Body pathology: smell function testing and α‐synuclein seed amplification

Mastenbroek SE, Collij LE, Vogel JW, ..., Ossenkoppele R, Hansson O

Alzheimers Dement 21 (S2) - [2025-12-00; online 2025-12-26]

DOI Crossref

AI Superresolution: Converting T1‐weighted MRI from 3T to 7T resolution toward enhanced imaging biomarkers for Alzheimer's disease

Gicquel M, Flood G, Zhao R, ..., Hansson O, Vogel JW

Alzheimers Dement 21 (S2) - [2025-12-00; online 2026-01-08]

DOI Crossref

Biological staging of Alzheimer's disease with the novel plasma eMTBR‐tau243 and %p‐tau217

Salvadó G, Horie K, Barthélemy NR, ..., Ossenkoppele R, Hansson O

Alzheimers Dement 21 (S2) - [2025-12-00; online 2025-12-24]

DOI Crossref

AI Superresolution: Converting T1‐weighted MRI from 3T to 7T resolution toward enhanced imaging biomarkers for Alzheimer’s disease

Gicquel M, Flood G, Zhao R, ..., Hansson O, Vogel JW

Alzheimers Dement 21 (S8) - [2025-12-00; online 2025-12-23]

DOI Crossref

Brain connectivity drives tau presence while regional vulnerability drives tau load in Alzheimer's disease

Xiao Y, Spotorno N, An L, ..., Hansson O, Vogel JW

Alzheimers Dement 21 (S2) - [2025-12-00; online 2025-12-25]

DOI Crossref

Disease timeline modelling of amyloid and tau PET reveals dynamic timescales of amyloid and tau accumulation in Alzheimer's disease

Young AL, Wijeratne PA, Aksman LM, ..., Vogel JW, Hansson O

Alzheimers Dement 21 (S2) - [2025-12-00; online 2026-01-07]

DOI Crossref

Benchmarking the AI‐based diagnostic potential of plasma proteomics for neurodegenerative disease in 17,710 people

An L, Xiao Y, Hristovska I, ..., Hansson O, Vogel JW

Alzheimers Dement 21 (S2) - [2025-12-00; online 2025-12-24]

DOI Crossref

Biological staging of Alzheimer’s disease with the novel plasma eMTBR‐tau243 and % ‐tau217

Salvadó G, Horie K, Barthélemy NR, ..., Ossenkoppele R, Hansson O

Alzheimers Dement 21 (S8) - [2025-12-00; online 2025-12-23]

DOI Crossref

Individual functional connectivity constraints on spatial progression of tau pathology in Alzheimer's disease

Behjat HH, Vogel JW, Strandberg O, ..., Hansson O, Ossenkoppele R

Alzheimers Dement 21 (S2) - [2025-12-00; online 2026-01-08]

DOI Crossref

Lu L, Binette AP, Janelidze S, ..., Hansson O, Mattsson‐Carlgren N

Alzheimers Dement 21 (S2) - [2025-12-00; online 2025-12-26]

DOI Crossref

Reference proteins to improve performance of core 1 and core 2 Alzheimer's disease CSF and plasma biomarkers

Karlsson L, Janelidze S, Barthélemy NR, ..., Mattsson‐Carlgren N, Hansson O

Alzheimers Dement 21 (S2) - [2025-12-00; online 2025-12-24]

DOI Crossref

Hemispheric Asymmetry of Amyloid Deposition Influences Asymmetric Tau Pathology in Alzheimer’s Disease

Anijärv TE, Smith R, Collij LE, ..., Spotorno N, Hansson O

Alzheimers Dement 21 (S8) - [2025-12-00; online 2025-12-23]

DOI Crossref

Coordinated multi‐cellular responses to Alzheimer's disease pathology reveal sex‐specific resilience signatures

Vilkaite G, An L, Xiao Y, ..., Mattsson‐Carlgren N, Vogel JW

Alzheimers Dement 21 (S1) - [2025-12-00; online 2025-12-24]

DOI Crossref

Hemispheric Asymmetry of Amyloid Deposition Influences Asymmetric Tau Pathology in Alzheimer's Disease

Anijärv TE, Smith R, Collij LE, ..., Spotorno N, Hansson O

Alzheimers Dement 21 (S2) - [2025-12-00; online 2025-12-25]

DOI Crossref

Disease timeline modelling of amyloid and tau PET reveals dynamic timescales of amyloid and tau accumulation in Alzheimer’s disease

Young AL, Wijeratne PA, Aksman LM, ..., Vogel JW, Hansson O

Alzheimers Dement 21 (S8) - [2025-12-00; online 2025-12-23]

PubMed DOI Crossref

Multimorbidity patterns and blood biomarkers of Alzheimer's disease in community-dwelling cognitively unimpaired older adults.

Marengoni A, Grande G, Valletta M, ..., Winblad B, Vetrano DL

Alzheimers Dement 21 (6) e70411 [2025-06-00; online 2025-06-23]

PubMed DOI Crossref

Machine learning prediction of tau-PET in Alzheimer's disease using plasma, MRI, and clinical data.

Karlsson L, Vogel J, Arvidsson I, ..., Mattsson-Carlgren N, Hansson O

Alzheimers Dement 21 (2) e14600 [2025-02-00; online 2025-02-22]

PubMed DOI Crossref

Proteomic signatures of Alzheimer's disease and Lewy body dementias: A comparative analysis.

Canal-Garcia A, Branca RM, Francis PT, ..., Pereira JB, Bereczki E

Alzheimers Dement 21 (1) e14375 [2025-01-00; online 2024-12-23]

Year 2024

DOI Crossref

Individual variation in proteomic cascades along the Alzheimer’s disease spectrum

Vogel JW, Vilkaite G, Binette AP, ..., Mattsson‐Carlgren N, Hansson O

Alzheimers Dement 20 (S2) - [2024-12-00; online 2025-01-09]

DOI Crossref

Data‐driven progression patterns of Aβ, tau, α‐synuclein and vascular pathology in a clinical population

Mastenbroek SE, Collij LE, Vogel JW, ..., Ossenkoppele R, Hansson O

Alzheimers Dement 20 (S2) - [2024-12-00; online 2025-01-09]

DOI Crossref

The mTOR‐4E‐BP1 axis controls microglia inflammatory and neurodegenerative responses

Bermudez S, Choi J, Kim S, ..., Healy LM, Sonenberg N

Alzheimers Dement 20 (S1) - [2024-12-00; online 2025-01-03]

DOI Crossref

Improved precision of Alzheimer’s disease fluid biomarkers when using Amyloid‐β40 or non‐phosphorylated tau as a reference

Karlsson L, Janelidze S, Horie K, ..., Mattsson‐Carlgren N, Hansson O

Alzheimers Dement 20 (S2) - [2024-12-00; online 2025-01-09]

DOI Crossref

Regional Amyloid Load Predicts Tau and Atrophy Dynamics

Chaggar P, Vogel JW, Binette AP, ..., Hansson O, Goriely A

Alzheimers Dement 20 (S2) - [2024-12-00; online 2025-01-09]

DOI Crossref

Associations between blood‐based biomarkers of Alzheimer’s disease and rate of global and domain‐specific cognitive decline in an elderly population with 15 years of follow‐up

Laukka EJ, Ekström I, Grande G, ..., Fratiglioni L, Vetrano DL

Alzheimers Dement 20 (S3) - [2024-12-00; online 2025-01-03]

DOI Crossref

Impact of regional MAPT, APOE, and Aβ on tau propagation in Alzheimer’s disease: Insights from a connectome‐based simulation model

Xiao Y, Strandberg O, Bazinet V, ..., Hansson O, Vogel JW

Alzheimers Dement 20 (S8) - [2024-12-00; online 2025-01-09]

DOI Crossref

Data‐driven progression patterns of Aβ, tau, α‐synuclein and vascular pathology in a clinical population

Mastenbroek SE, Collij LE, Vogel JW, ..., Ossenkoppele R, Hansson O

Alzheimers Dement 20 (S9) - [2024-12-00; online 2025-01-09]

DOI Crossref

Blood‐based biomarkers of Alzheimer’s disease and 15‐year rate of olfactory decline in an elderly population

Ekström I, Vetrano DL, Ruane R, ..., Fratiglioni L, Laukka EJ

Alzheimers Dement 20 (S2) - [2024-12-00; online 2025-01-09]

DOI Crossref

Proteomics analysis characterizing new markers related to Aβ plaques and tau tangles pathologies

Binette AP, Wennström M, Strandberg O, ..., Vogel JW, Hansson O

Alzheimers Dement 20 (S2) - [2024-12-00; online 2025-01-09]

DOI Crossref

Visual classification of tau‐PET detects four subtypes with different long‐term outcomes

Boccalini C, Mathoux G, Hristovska I, ..., Vogel JW, Garibotto V

Alzheimers Dement 20 (S9) - [2024-12-00; online 2025-01-09]

DOI Crossref

Unlocking Tau PET Accessibility: a Machine Learning‐Based Prediction of Tau Pathology from Plasma, MRI and Clinical Variables

Karlsson L, Vogel JW, Strandberg O, ..., Mattsson‐Carlgren N, Hansson O

Alzheimers Dement 20 (S2) - [2024-12-00; online 2025-01-09]

DOI Crossref

Visual classification of tau‐PET detects four subtypes with different long‐term outcomes

Boccalini C, Mathoux G, Hristovska I, ..., Vogel JW, Garibotto V

Alzheimers Dement 20 (S2) - [2024-12-00; online 2025-01-09]

PubMed DOI Crossref

Blood biomarkers of Alzheimer's disease in the community: Variation by chronic diseases and inflammatory status.

Valletta M, Vetrano DL, Rizzuto D, ..., Fratiglioni L, Grande G

Alzheimers Dement 20 (6) 4115-4125 [2024-06-00; online 2024-05-08]

Year 2023

DOI Crossref

Novel CSF tau biomarkers can be used for disease staging of sporadic Alzheimer’s

Salvadó G, Horie K, Barthélemy NR, ..., Bateman RJ, Hansson O

Alzheimers Dement 19 (S14) - [2023-12-00; online 2023-12-25]

DOI Crossref

Proteomics Analysis Identifying New Markers Related to Alzheimer’s Disease Pathology In Vivo

Binette AP, Salvadó G, Spotorno N, ..., Janelidze S, Hansson O

Alzheimers Dement 19 (S14) - [2023-12-00; online 2023-12-25]

DOI Crossref

Identification of Distinct and Shared Biomarkers in Cerebral Small Vessel Disease (SVD) through Proteomic Profiling of Cerebrospinal Fluid

Hristovska I, Kumar A, Binette AP, ..., Vogel JW, Hansson O

Alzheimers Dement 19 (S24) - [2023-12-00; online 2023-12-25]

DOI Crossref

Uncovering distinct spatial‐temporal trajectories of Lewy‐type α‐synuclein pathology: a Subtype and Stage Inference model analysis

Mastenbroek SE, Vogel JW, Collij LE, ..., Beach TG, Hansson O

Alzheimers Dement 19 (S14) - [2023-12-00; online 2023-12-25]

DOI Crossref

Shared and disparate transcriptomic signatures associated with cortical atrophy change in genetic behavioral variant frontotemporal degeneration

Shen T, Vogel JW, Van Deerlin VM, ..., Irwin DJ, McMillan CT

Alzheimers Dement 19 (S12) - [2023-12-00; online 2023-12-25]

PubMed DOI Crossref

A structural and resting-state functional connectivity investigation of the pulvinar in elderly individuals and Alzheimer's disease patients.

Velioglu HA, Ayyildiz B, Ayyildiz S, ..., Bayraktaroglu Z, Yulug B

Alzheimers Dement 19 (7) 2774-2789 [2023-07-00; online 2022-12-28]

PubMed DOI Crossref

A glycan epitope correlates with tau in serum and predicts progression to Alzheimer's disease in combination with APOE4 allele status.

Zhou RZ, Vetrano DL, Grande G, ..., Tjernberg L, Schedin-Weiss S

Alzheimers Dement 19 (7) 3244-3249 [2023-07-00; online 2023-04-12]

DOI Crossref

Relation of different CSF biosignatures to clinical phenotypes in a memory clinic cohort

Alanko V, Mravinacová S, Kivipelto M, ..., Nilsson P, Sandebring‐Matton A

Alzheimers Dement 19 (S2) - [2023-06-00; online 2023-06-16]

Year 2016

PubMed DOI Crossref

Synaptic proteins predict cognitive decline in Alzheimer's disease and Lewy body dementia.

Bereczki E, Francis PT, Howlett D, ..., Ballard C, Aarsland D

Alzheimers Dement 12 (11) 1149-1158 [2016-11-00; online 2016-05-22]

DOI Crossref

P2‐064: Identification of Differentially Expressed Proteins in Alzheimer's Disease Through The Screening of The Protein Content of The Prefrontal Cortex of Alzheimer's Disease Patients Using Protein Microarrays

San Segundo-Acosta P, Garranzo-Asensio M, Montero-Calle A, ..., Villalba M, Barderas R

Alzheimers Dement 12 (7S_Part_13) - [2016-07-00; online 2016-07-00]